Morgan Stanley Reiterates Overweight Rating on UnitedHealth Group (UNH)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
UnitedHealth Group Announces Leadership Transition
May 13, 2025 6:30 AM EDTStephen J. Hemsley named Chief Executive Officer Company suspends 2025 outlook as medical expenditures expected to be higher than anticipated Company expects to return to growth in 2026
UnitedHealth Group (NYSE: UNH) today announced the appointment of Stephen J. Hemsley as its chief executive officer, effective immediately, following Andrew Wittys decision to step down as CEO for personal reasons. Hemsley, who served as company CEO from 2006-2017, will remain chairman of the companys Board of Directors and Witty will... More
ROSEN, A LEADING LAW FIRM, Encourages UnitedHealth Group Incorporated Investors to Secure Counsel Before Important Deadline in Securities Class Action - UNH
May 12, 2025 10:33 PM EDTNew York, New York--(Newsfile Corp. - May 12, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit has been filed on behalf of purchasers of securities of UnitedHealth Group Incorporated (NYSE: UNH) between December 3, 2024 and April 16, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 7, 2025.
SO WHAT: If you purchased UnitedHealth securities during the Class Period you may be... More
ROSEN, LEADING INVESTOR COUNSEL, Encourages UnitedHealth Group Incorporated Investors to Secure Counsel Before Important Deadline in Securities Class Action - UNH
May 11, 2025 10:28 PM EDTNew York, New York--(Newsfile Corp. - May 11, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit has been filed on behalf of purchasers of securities of UnitedHealth Group Incorporated (NYSE: UNH) between December 3, 2024 and April 16, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 7, 2025.
SO WHAT: If you purchased UnitedHealth securities during the Class Period you may be... More
UNH INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that UnitedHealth Group Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
May 11, 2025 4:02 PM EDTNew York, New York--(Newsfile Corp. - May 11, 2025) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against UnitedHealth Group Incorporated ("UnitedHealth" or "the Company") (NYSE: UNH) and certain of its officers.
Class Definition
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired UnitedHealth securities between December 3, 2024 and April 16, 2025, both dates inclusive (the "Class Period"). Such investors are encouraged... More
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages UnitedHealth Group Incorporated Investors to Secure Counsel Before Important Deadline in Securities Class Action - UNH
May 10, 2025 10:28 PM EDTNew York, New York--(Newsfile Corp. - May 10, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit has been filed on behalf of purchasers of securities of UnitedHealth Group Incorporated (NYSE: UNH) between December 3, 2024 and April 16, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 7, 2025.
SO WHAT: If you purchased UnitedHealth securities during the Class Period you may be... More
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages UnitedHealth Group Incorporated Investors to Secure Counsel Before Important Deadline in Securities Class Action - UNH
May 9, 2025 10:27 PM EDTNew York, New York--(Newsfile Corp. - May 9, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit has been filed on behalf of purchasers of securities of UnitedHealth Group Incorporated (NYSE: UNH) between December 3, 2024 and April 16, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 7, 2025.
SO WHAT: If you purchased UnitedHealth securities during the Class Period you may be... More
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in UnitedHealth Group Incorporated of Class Action Lawsuit and Upcoming Deadlines – UNH
May 9, 2025 2:50 PM EDTNEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against UnitedHealth Group Incorporated (UnitedHealth or the Company) (NYSE: UNH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of... More

